2001
DOI: 10.1210/endo.142.11.8593
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Central Amylin Signaling Increases Food Intake and Body Adiposity in Rats

Abstract: Amylin is a 37-amino acid peptide hormone that is co-secreted with insulin by pancreatic beta cells in response to feeding. We recently reported that amylin potently reduces food intake, body weight, and adiposity when delivered into the 3rd cerebral ventricle (i3vt) of rats. We have now infused i3vt a specific antagonist (AC187) to ascertain the physiological relevance of central amylin in the control of energy balance. After establishing the ability of i3vt AC187 to block the anorexic effect of i3vt amylin, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
59
3

Year Published

2003
2003
2018
2018

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 137 publications
(66 citation statements)
references
References 0 publications
4
59
3
Order By: Relevance
“…Thus, upcoming studies should explore and define the brain areas involved in the ability of sCT to regulate alcohol-mediated behaviours. Moreover, in light of the findings that amylin receptor inhibition increases food intake as well as body adiposity in rats (Rushing et al 2001;Reidelberger et al 2004), future experiments exploring the possibility that an amylinergic receptor antagonist increases alcohol intake are warranted.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, upcoming studies should explore and define the brain areas involved in the ability of sCT to regulate alcohol-mediated behaviours. Moreover, in light of the findings that amylin receptor inhibition increases food intake as well as body adiposity in rats (Rushing et al 2001;Reidelberger et al 2004), future experiments exploring the possibility that an amylinergic receptor antagonist increases alcohol intake are warranted.…”
Section: Discussionmentioning
confidence: 99%
“…The amylin receptor antagonist AC187 (R&D Systems, Minneapolis, MN, USA) was dissolved in aCSF. Dose responses for drugs were selected from the literature (Hayes et al, 2011;Lutz et al, 2000;Mollet et al, 2004;Rushing et al, 2001Rushing et al, , 2000Wielinga et al, 2007).…”
Section: Drugsmentioning
confidence: 99%
“…To address this issue, rats received counterbalanced intra-VTA injections of the amylin receptor antagonist AC187 (Mollet et al, 2004;Rushing et al, 2001;0.3 .05)). Subsequent chow intake (b), total 24 h energy intake (c), and 24 h body weight change (d) were also reduced by sCT, but only by the higher (0.04 mg) dose of drug (*significantly different from vehicle (Po0.05)).…”
Section: Amylin Receptor Signaling In the Vta Is Physiologically And mentioning
confidence: 99%
“…When administered exogenously (peripherally or centrally), acute amylin dose-dependently decreases food intake, causing a decrease in meal size though having no effect on the intermeal interval [14,15]. Furthermore, the decrease in meal size is not a result of an aversive or toxic effect of amylin [14,16].…”
Section: Introductionmentioning
confidence: 99%